Endoscopic therapy for bleeding esophageal varices improves the outcome of Child C cirrhotic patients

Journal of Gastroenterology and Hepatology (Australia)

Volumn 21, Issue 11, 2006, Pages 1704-1709

  Hori, Shinichiro ^a   Takaki, Akinobu ^a   Okada, Hiroyuki ^a   Fujiwara, Akiko ^a   Takenaka, Ryuta ^a   Makidono, Chiho ^a   Shiratori, Yasushi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Child C cirrhosis; Endoscopic therapy; Esophageal varices

Indexed keywords

BILIRUBIN;

ADULT; AGED; ARTICLE; ASCITES; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; DISEASE CONTROL; ENDOSCOPIC SCLEROTHERAPY; ENDOSCOPIC THERAPY; ESOPHAGUS VARICES BLEEDING; FEMALE; HEMOSTASIS; HUMAN; LIGATION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; MEDICAL PARAMETERS; MORTALITY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE; UNIVARIATE ANALYSIS;

EID: 33748763811     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2006.04267.x     Document Type: Article

References (27)

1. Sherlock S, Dooley J. Disease of the Liver and Biliary System. Oxford: Blackwell Science, 1997; 135-80.
2. McCormic PA, O'Keefe C. Improving prognosis following a first variceal haemorrhage over four decades. Gut 2001; 49: 682-5.
3. Graham DY, Smith JL. The course of patients after variceal hemorrhage. Gastroenterology 1981; 80: 800-9.
4. Garcia-Tsao G. Current management of the complications of cirrhosis and portal hypertension: variceal hemorrhage, ascites, and spontaneous bacterial peritonitis. Gastroenterology 2001; 120: 726-48.
5. Larson AW, Cohen H, Zweiban B et al. Acute esophageal variceal sclerotherapy. Results of a prospective randomized controlled trial. JAMA 1986; 255: 497-500.
6. Westaby D, Hayes PC, Gimson AES, Polson RJ, Williams R. Controlled clinical trial of injection sclerotherapy for active variceal bleeding. Hepatology 1989; 9: 274-7.
7. Stiegmann GV, Goff JS, Michaletz-Onody PA et al. Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices. N. Engl. J. Med. 1992; 326: 1527-32.
8. Avgerinos A, Armonis A, Stefanidis G et al. Sustained rise of portal pressure after sclerotherapy, but not band ligation, in acute variceal bleeding in cirrhosis. Hepatology 2004; 39: 1623-30.
9. Child CG. The Liver and Portal Hypertension. Philadelphia: W.B. Saunders, 1964; 50-1.
10. Nishikawa Y, Hosokawa Y, Doi T et al. Evaluation of endoscopic injection sclerotherapy with and without simultaneous ligation for the treatment of esophageal varices. J. Gastroenterol. 1999; 34: 159-62.
11. Stiegmann GV, Cambre T, Sun JH. A new endoscopic elastic band ligating device. Gastrointest. Endosc. 1986; 32: 230-3.
12. Sharara AI, Rockey DC. Gastroesophageal variceal hemorrhage. N. Engl. J. Med. 2001; 345: 669-81.
13. Sarin Shiv K, Wadhawan M, Agawal SR et al. Endoscopic variceal ligation plus propranolol versus endoscopic variceal ligation alone in primary prophylaxis of variceal bleeding. Am. J. Gastroenterol. 2005; 100: 797-804.
14. de la Pena J, Brullet E, Sanchez-Hernandez E et al. Variceal ligation plus nadolol compared with ligation for prophylaxis of variceal rebleeding: a multicenter trial. Hepatology 2005; 3: 572-8.
15. Jutabha R, Jensen DM, Martin P et al. Randomized study comparing banding and propranolol to prevent initial variceal hemorrhage in cirrhotics with high-risk esopahgeal varices. Gastroenterology 2005; 128: 870-81.
16. El-Serag HB, Everhart JE. Improved survival after variceal hemorrhage over an 11-year period in the Department of Veterans Affairs. Am. J. Gastroenterol. 2000; 95: 3566-73.
17. Chalasani N, Kahi C, Francois F et al. Improved patient survival after acute variceal bleeding: a multicenter, cohort study. Am. J. Gastroenterol. 2003; 98: 653-9.
18. Pinto HC, Abrantes A, Esteves AV, Almeida H, Correia P. Long-term prognosis of patients with cirrhosis of the liver and upper gastrointestinal bleeding. Am. J. Gastroenterol. 1989; 84: 1239-43.
19. del Olmo JA, Pena A, Serra MA, Wassel AH, Benages A, Rodrigo JM. Predictors of morbidity and mortality after the first episode of upper gastrointestinal bleeding in liver cirrhosis. J. Hepatol. 2000; 32: 19-24.
20. Carbonell N, Pauwels A, Serfaty L, Fourdan O, Levy VG, Poupon R. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology 2004; 40: 652-9.
21. Gines P, Cardenas A, Arroyo V, Rodes J. Management of cirrhosis and ascites. N. Engl. J. Med. 2004; 350: 1646-54.
22. Planas R, Balleste B, Alvarez MA et al. Natural history of decompensated hepatitis C virus-related cirrhosis. A study of 200 patients. J. Hepatol. 2004; 40: 823-30.
23. Bustamante J, Rimola A, Ventura PJ et al. Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J. Hepatol. 1999; 30: 890-5.
24. Schafer DF, Sorrell MF. Hepatocellular carcinoma. Lancet 1999; 353: 1253-7.
25. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003; 362: 1907-17.
26. Gines P, Quintero E, Arroyo V et al. Compensated cirrhosis: natural history and prognostic factors. Hepatology 1987; 7: 122-8.
27. Lang BH, Poon RT, Fan ST, Wong J. Outcomes of patients with hepatocellular carcinoma presenting with variceal bleeding. Am. J. Gastroenterol. 2004; 99: 2158-65.